As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
Here are the most listened to Diabetech podcast episodes of 2025, featuring expert interviews, diabetes tech and cure resear, and the future of diabetes technology.
How to Optimize Basal Insulin Settings for More Stable Glucose
I sat down with CDCES Gary Scheiner to discuss why basal insulin matters, how to know when it's off, and what stable basal looks like for insulin pumps and MDI.
How to Optimize CGM Alerts & Settings for the Best Results
I spoke with CDCES Gary Scheiner about how to take full advantage of continuous glucose monitor settings and alerts for the strongest diabetes management.
How Secure Is Your Insulin Pump? A Cybersecurity Expert Explains
A cybersecurity expert explains the precautions behind insulin pumps, CGMs, and why managing diabetes in secure government facilities requires a different level of protection.
We unpack how major companies are reimagining insulin delivery through tubeless designs, smarter algorithms, and the path to a fully automated insulin system.
We Spoke with Breakthrough T1D’s CEO About its Mission to Cure Type 1 Diabetes
We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.
SynchNeuro's CGM Could Measure Glucose Levels Using Brainwaves
A new behind-the-ear EEG sensor aimed at the pre-diabetes and type 2 diabetes community is being designed to read blood glucose levels directly from brain activity.
How Simulation Could Fast-Track The Diabetes Tech Review Process
I sit down with Lane Desborough to discuss his work in the diabetes space and AIDIF--his current project working to streamline diabetes innovations with simulations.
Tandem Diabetes' New Tech: Tubeless Mobi Preview & 7-Day Infusion Set Demo
We go an exclusive hands-on demo of Tandem's SeadiSet infusion set that lasts seven days - plus more info on tubeless Mobi, an upcoming Android app, and product releases worldwide.
T1Ds Are Using GLP-1s: The Latest Research & The Road To Coverage
Medications like Ozempic, Wegovy, and Mounjaro are showing promising results for people with type 1 diabetes — but they’re still not approved for this use.
How DIYers Beat Pharma to Build The First Automated Insulin System
Before any company had a commercial AID system, a misdiagnosed techie and a band of DIYers rewrote the future of diabetes by combining pump and cgm data.
